Seres Therapeutics Inc.

(MCRB) Trade

By |

Profile

Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treats dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-155.

Contact Information

Website: www.serestherapeutics.com
Email: ctanzi@serestherapeutics.com
Main Phone: +1 617 945-9626
Address: 200 Sidney Street
Address 2: 4th Floor
State: MA
City / Town: Cambridge
Country: USA
Postal Code: 02139

Issuer Information

Exchange: NGS
CEO: Roger J. Pomerantz
Employees: 138
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 6.57 $ -0.12 (-1.79%)
Last Price 6.57 Change $ -0.12 Change % -1.79 Tick N/A
Bid 6.55 Bid Size 100.00 Ask 6.58 Ask Size 200.00
Open 6.66 High 7.04 Low 6.54 Prev Close 6.69
Last Trade Volume 44,692 52 Wk Hi 11.35 52 Wk Low 5.64
Market Cap 268.4 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 40,855,909.00 EPS (TTM) -2.63 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 2 16
Number of Buys 0 8
Number of Sells 2 8
Net Activity -14512 149724
Last 10 Buys Shares
N/A 0
Last 10 Sell Shares
Roger J. Pomerantz 1,000
John G. Aunins 1,000
Eric D. Shaff 1,000
Michele Trucksis 1,000
David N. Cook 1,000
John G. Aunins 1,000
John G. Aunins 1,000
John G. Aunins 1,000
John G. Aunins 1,000
Michele Trucksis 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 20 20 20 20
Low Target Price Estimate 13 13 13 13
Mean Target Price Estimate 16.75 16.75 16.75 16.75
Standard Deviation 2.99 2.99 2.99 2.99
Date of Most Recent Estimate 05/22/18 05/22/18 05/22/18 05/22/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 4 4 4 5
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.4 1.4 1.4 1.33